GGrantIndex
← Search

Commercialization of automated mobile device for accurate comprehensive refraction

$717,387R44FY2022EYNIH

Plenoptika, Inc., Cambridge MA

Investigators

Linked publications, trials & patents

Abstract

Summary The goal of this CRP SBIR application is to commercialize QuickSee Plus that was researched and developed during SBIR Phase 2 work. QuickSee Plus, will be a unique tool for eye care professionals that enables comprehensive refraction (objective and subjective) in a single, portable package. It will provide tremendous value for eye care professionals as it improves their efficiency within the clinic and extends their reach outside the clinic, thereby, greater accessibility to refractive eye care for health disparity populations

View original record on NIH RePORTER →